Diagnosing SARS-CoV-2 associated Guillain-Barre syndrome requires cerebro-spinal-fluid studies.

Finsterer, Josef; Scorza, Fulvio A; Scorza, Carla A; Fiorini, Ana C

Finsterer, Josef; Scorza, Fulvio A; Scorza, Carla A; Fiorini, Ana C.

Finsterer J; Klinik Landstrasse, Messerli Institute, Vienna, Austria. Electronic address: fifigs1@yahoo.de.
Scorza FA; Disciplina de Neurociência, Universidade Federal de São Paulo/Escola Paulista de Medicina (UNIFESP/EPM), São Paulo, Brazil. Electronic address: scorza@unifesp.br.
Scorza CA; Disciplina de Neurociência, Universidade Federal de São Paulo/Escola Paulista de Medicina (UNIFESP/EPM), São Paulo, Brazil.
Fiorini AC; Programa de Estudos Pós-Graduado em Fonoaudiologia, Pontifícia Universidade Católica de São Paulo (PUC-SP), Brazil; Departamento de Fonoaudiologia, Escola Paulista de Medicina/Universidade Federal de São Paulo (EPM/UNIFESP), São Paulo, Brazil. Electronic address: acfiorini@pucsp.br.

J Neuroimmunol ; 357: 577609, 2021 08 15.

Article in English | MEDLINE | ID: covidwho-1230623

Subject(s)

COVID-19; Guillain-Barre Syndrome; Guillain-Barre Syndrome/complications; Guillain-Barre Syndrome/diagnosis; Humans; SARS-CoV-2

Keywords

COVID-19; Cerebro-spinal fluid; Guillain-Barre syndrome; Nerve conduction studies; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Guillain-Barre Syndrome / COVID-19 Type of study: Diagnostic study Topics: Long Covid Limits: Humans Language: English Journal: J Neuroimmunol Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google